Source link : https://www.newshealth.biz/health-news/finally-a-new-option-for-posttraumatic-stress-disorder/
A drug that combines the atypical antipsychotic brexpiprazole and the selective serotonin reuptake inhibitor sertraline provides significantly greater relief of posttraumatic stress disorder (PTSD) symptoms than sertraline plus placebo, results of a phase 3 trial showed. The medication is currently under review by the US Food and Drug Administration (FDA) and if approved, will be […]
Author : News Health
Publish date : 2024-12-20 11:09:16
Copyright for syndicated content belongs to the linked Source.
inHealth